KURA ONCOLOGY, INC. COMMON STOCK SALES AGREEMENTSales Agreement • November 2nd, 2023 • Kura Oncology, Inc. • Pharmaceutical preparations • New York
Kura Oncology, Inc., a Delaware corporation (the “Company”), Leerink Partners LLC (“Leerink Partners”), as lead sales agent, and Cantor Fitzgerald & Co. (“Cantor”, and together with Leerink Partners, the “Agents”), as sales agent, confirm their agreement (this “Agreement”) as follows:
Executive Employment Agreement for Brian PowlExecutive Employment Agreement • November 2nd, 2023 • Kura Oncology, Inc. • Pharmaceutical preparations • California
This Executive Employment Agreement (the “Agreement”), entered into between Kura Oncology, Inc. (the “Company”) and Brian Powl (the “Executive”) (collectively, the “Parties”), is effective as of August 14, 2023 (the “Effective Date”).
ContractLease • November 2nd, 2023 • Kura Oncology, Inc. • Pharmaceutical preparations
This First Amendment to Lease (this “Amendment”), is made as of the 30th day of August, 2023, by and between EAST OFFICE OPERATING LIMITED PARTNERSHIP, a
FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • November 2nd, 2023 • Kura Oncology, Inc. • Pharmaceutical preparations • California
THIS FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Amendment”), dated as of October 2, 2023 (the “Amendment Effective Date”), is entered into by and between Kura Oncology, Inc., a Delaware corporation, together with any Subsidiaries from time to time party to the Loan Agreement (collectively referred to as “Borrower”), the several banks and other financial institutions or entities from time to time parties to the Loan Agreement (collectively, referred to as “Lender”) that are party hereto and HERCULES CAPITAL, INC., a Maryland corporation, in its capacity as administrative agent and collateral agent for itself and Lender (in such capacity, “Agent”).
